Шындық па, әлде жалған ба?
a) Дезодоранттар тек дененің иісін жасырады және бөлінетін тердің мөлшерін өзгертпейді.
ә) Тер теріде бактериялар ыдыраған кезде иіс шығарады.
б) Антиперспиранттар тер бөлінуін тежегендіктен, қызып кетуге әкелуі мүмкін.
в) Антиперспиранттар сүт безі обырын тудырады.
Сәйкестендіру
А бағанындағы ингредиенттерді Ә бағанындағы олардың тиісті ингредиенттерінің санатымен
сәйкестендіріңіз.
A
бағаны
Ә бағаны
A. Алюминий-цирконий тетрахлор-
гид
1.
Микробқа қарсы
агент
Ә. Жүгері крахмалы
2. Антиперспирантты
белсенді зат
Б. Циклометикон
3. Қарындаштағы
қатайтқыштар
В. Этанол
4. Ылғалдайтын зат
Г. Сутектендірілген майсана майы
5. Ионды емес беттік
белсенді зат
F. Изостеарат-20
6. Иісті басатын
дезодорант
Д. Пропиленгликоль
7. Көмескілендіретін
агент
Е. Кватерниум-18 гекторит
8. Силикон майы
Ж. Титан диоксиді
9. Суспензиялайтын
агент
З. Мырыш рицинолеаты
10. Текстуралаушы
агент
ӘДЕБИЕТТЕР ТІЗІМІ
277
1.
Market Research: Deodorants and Antiperspirants, US, Mintel Interna- tional Group Ltd.
Accessed 3/14/2014 at http://www.marketresearch.com/ Mintel-International-Group-Ltd-v614/Deodorants-
Antiperspirants-7086246/
2.
Standring, S.:
Gray’s Anatomy: The Anatomical Basis of Clinical Practice
, 39th Edition, London: Churchill
Livingstone, 2004.
3.
Venkataramm M.:
ACSI Textbook on Cutaneus and Aesthetic Surgery
. Clayton: JP Medical Ltd, 2012.
4.
Eroschenko, V. P., di Fiore, M. S. H.:
DiFiore’s Atlas of Histology with Functional Corre- lations
, Philadelphia:
Lippincott Williams & Wilkins, 2012.
5.
Udby, L., Cowland, J. B., Johnsen, A. H., et al. An ELISA for SGP28/CRISP-3, a cysteine-rich secretory protein
in human neutrophils, plasma and exocrine secretions.
J Immunol Methods
. 2002;263:43 – 55.
6.
Quinton, P. N., Elder, H., Jenkinson, D. M., Bovell, D. L.: Structure and Function of Human Sweat Glands, In:
Laden, K., ed.:
Antiperspirant and Deodorants
, 2nd Edition, New York: Marcel Dekker, 1999;19.
7.
Labows, J. N., Preti, G., Hoelzle, E., et al. Steroid analysis of human apocrine secretion.
Steroids
. 1979;34:249
– 258.
8.
Jacoby, R. B., Brahams, J. C., Ansari, S. A., et al.: Detection and quantification of apocrine secreted odor-
binding protein on intact human axillary skin.
Int J Cosmet Sci
. 2004;26:37 – 46.
9.
Kanlayavattanakul, M., Lourith, N.: Body malodours and their topical treatment agents.
Int J Cosmet Sci
.
2011;33(4):298 – 311.
10.
Taylor, D., Daulby, A., Grimshaw, S., et al.: Characterization of the microflora of the human axilla.
Int J Cosmet
Sci
. 2003;25(3):137 – 145.
11.
Bhutta, M. F.: Sex and the nose: human pheromonal responses.
J R Soc Med
. 2007;100:268 – 274.
12.
Preti, G., Willse, A., Labows, J. N., et al. On the definition and measurement of human
scent: comments on
Curran et al.
J Chem Ecol
. 2006;32:1613 – 1616.
13.
Rados, C.: FDA antiperspirant awareness: it’s mostly no sweat.
FDA Consum
. 2005;39(4):18 – 24.
14.
Partick, B., Thompson, J.:
An Uncommon History of Common Things
, Washington: National Geographic,
2011;193.
15.
Plinius.
Naturkunde
. 35,52
16.
Rimmel, E.
The Book of Perfumes
, London: Chapman & Hall, 1865.
17.
Crawford, T. H., Nagarajan, T. S.
J Soc Cosmet Chem
. 1954;5:202.
18.
Barraclough, G.
The Times Atlas of World History
, London: Times Books, 1978.
19.
MUM: Accessed 3/13/14 at http://www.mum-deo.com/about-mum/history/
20.
IFSCC
Monograph No 6. Antiperspirants and Deodorants, Principles of Underarm Tech- nology
, Weymouth:
Micelle Press, 1998.
21.
Cuzner, B., Klepak, P.: Antiperspirants and Deodorants, In: Butler, H.:
Poucher’s Perfumes Cosmetics and Soaps
,
9
th Edition, London: Chapman & Hall, 1993:3 – 26.
22.
Life
, 1949;25.
23.
42 FR 41374, 1977.
24.
EPA: Protecting the Stratospheric Ozone Layer Last Update: 3/6/2012, Accessed 3/10/2014 at http://www.epa.
gov/air/caa/peg/stratozone.html
25.
Statista 2014: U.S. Households: Which Forms of Deodorant and Antiper- spirant Do You Use Most Often
in 2013, Accessed 3/12/14 at http://www.
statista.com/statistics/275489/us-households-form-of-deodorants-
and-anti-perspirants- used/
26.
Ruchinskas, R.: Hyperhidrosis and anxiety: chicken or egg?
Dermatology
, 2007;214(3):195 – 196.
27.
Adar, R., Kurchin, A., Zweig, A., et al.: Palmar hyperhidrosis and its surgical treatment: a report of 100 cases.
Ann Surg
. 1977;186(1):34 – 41.
28.
Rados, C.: Antiperspirant Awareness: It’s Mostly No Sweat.
FDA Consumer Magazine.
2005. Accessed on
2/3/14 at www.medicinenet.com/script/main/art.
asp?articlekey
=
53207
29.
Hornberger, J., Grimes, K.: Recognition, diagnosis and treatment of primary focal hyper- hidrosis.
J Am Acad
278
Dermatol
. 2004;51:274 – 286.
30.
Johansen, J. D., Rastogi, S. C., Bruze, M., et al.: Deodorants: a clinical provocation study in fragrance-sensitive
individuals.
Contact Dermatitis
. 1998;39(4):161 – 165.
31.
Sato, K., Kane, N., Soos, G., et al.: The eccrine sweat gland: basic science and disorders of eccrine sweating.
Derm Found
. 1995;29:1 – 11.
32.
Can too much antiperspirant cause me to overheat?
Popular Science
2013;282(1):74.
33.
Burry, J. S., Evans, R. L., Rawlings, A. V., et al.: Effect of antiperspirant on whole body sweat rate and
thermoregulation.
Int J Cosm Sci
. 2003;25:189 – 192.
34.
Geria, N.: Fragrancing antiperspirants and deodorants.
Cosmet Toiletries
. 1990; 105:41 – 45.
35.
Lamp, J. H.: Sodium bicarbonate: an excellent deodorant.
J Invest Dermatol
. 1946; 7:131 – 133.
36.
Berschied, J. R.: Antiperspirant-deodorant cosmetic stick products containing active agent
particles in organic
matrix, which matched densities for homogeneous products. Patent WO 9413256.
37.
Winston, A. E. Microporous alkali metal carbonate powder — comprises particles of aver- age particle size of 0.1
to 50 microns, surface area of 5 to 20 sq.m/f, average pore size of 10 to 500 nm and total pore volume of 0.1 to 2
cc/g and is useful as lightweight deodorant ingredient. Patent WO 9424996.
38.
Zekorn, R.,
Deowirkstoff auf Basis Zinkricinoleat
.
Parf Kosmet
. 1996;77:682 – 684.
39.
Zekorn, R.: Zinc ricinoleate.
Cosmet Toiletries
. 1997;112:37 – 40.
40.
Kanda, F., Yagi, E., Fukuda, M., et al.: Quenching short chain fatty acids responsible for human body odors.
Cosmet Toiletries.
1993;108:67 – 72.
41.
Yagi, E., Fukuda, M., Ota, T., et al.: Deodorants containing hydroxylapatite and synthetic resins, Patent JP
62135411, 1987.
42.
Thurmon, F. M., Ottenstein B.: Studies on the chemistry of human perspiration with espe- cial reference to its
lactic acid content.
J Invest Dermatol
. 1952;18:333 – 339.
43.
Ikai, K.: Deodorizing experiments with ion-exchange resins.
J Invest Dermatol
. 1954;23:411 – 422.
44.
Nakahara, Y., Shimai, Y., Yoshikawa, T.: Body deodorant powder containing spherical, porous, hollow
microparticles. Patent JP 62212315, 1987.
45.
Charig, A., Froebe, C., Simone, A., et al.: Inhibitor of odor producing axillary bacterial exoenzymes.
J Soc
Cosmet Chem
. 1991;42:133 – 145.
46.
Use of monoalkyl or dialkyl ester(s) of aliphatic, satd. dicarboxylic acids. DE 4343265 A1
47.
Process of suppressing odors employing deodorants containing esters of citric acid US 4010253 A
48.
Cox, A. R.: Efficacy of the antimicrobial agent triclosan in topical deodorant products.
J Soc Cosmet Chem
.
1987;38:223 – 231.
49.
Dillenburg, H., Jakobsonm G., Klein, W., et al.: Cosmetic deodorant preparations contain- ing di- or triglycerin
esters. Patent No. EP 666732 Al/Bl.
50.
Abrutyn, E. S.: Antiperspirants and Deodorants, In: Drealos, Z. D.:
Cosmetic Dermatol- ogy
, Hoboken: Wiley
Blackwell, 2010.
51.
Abrutyn, E. S.: Antiperspirants.
Cosmet Toiletries
. 2011;126(11):780 – 786.Swaile, D. F.: Variation in efficacy of
commercial antiperspirant products based on differ- ences in active composition and manufacturing method. In:
61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003:P337.
52.
Reller, H. H., Luedders, W. L.: Mechanism of action of metal salt anti-perspirants.
Adv Mod Toxicol
. 1977;4:18
– 54.
53.
Quatrale, R. P., Coble, R. P., Stoner, K. L., et al.: The mechanism of antiperspirant action of aluminum salts.
III. Histological observations of human eccrine sweat glands inhibited by aluminum zirconium chlorohydrate
glycine complex.
J Soc Cosm Chem
. 1981;32:195 – 222.
54.
Wild, J. E., Lanzalaco, A. C., Swaile, D. F.: Antiperspirants, In: Drealos, Z. D., Thaman,
55.
L. A.: Cosmetic Science and Technology, Vol 30. Cosmetic Formulation of Skin Care Products, New York:
Taylor & Francis, 2006.
56.
Abrutyn, E.: Antiperspirant and Deodorants, In: Reiger, M. M.:
Harry’s Cosmetology
, 8th Edition, New York:
Chemical Publishing Company Inc., 2000.
57.
FDA: Title 21, Chapter 1, Subchapter D, Part 310, Subchapter G, Part 700:
Aerosol drug and cosmetic
279
products containing zirconium, final rule,
Fed Reg
, 1977;42(158):41374 – 41376.
58.
Abrutyn, E. S.: Antiperspirant sticks, soft solids and gels,
Cosmet Toiletries
. 2009;124(5):24 – 35.
59.
A Quick Guide to Dow Corning® brand Silicone Emulsifiers, Accessed 3/10/2014 at http://www.dowcorning.
com/content/publishedlit/27-1369.pdf?wt.svl
=
BPC_pFace_FaB2
60.
Schreiber, J.: Antiperspirants, In: Barel, A. O., Paye, M., Maibach, H. I.:
Handbook of Cosmetic Science and
Technology
, 3rd Edition, New York: Informa Healthcare, 2009.
61.
Abrutyn, E. S., Bahr, B. C.: Formulation enhancements for underarm applications.
Cosmet Toiletries
. 1993;108:51
– 54.
62.
Alexander, P.: Monograph antiperspirants and deodorants.
SOFW
. 1994;120:117 – 121.
63.
ICI Speciality Chemicals: A new emollient for antiperspirant sticks.
HAPPI
. 1989;50 – 51.
64.
Osborne, G. E., Lausier, J. M.: Statistical evaluation of vehicle effect on antiperspirant activity with a limited
number of subjects.
J Soc Cosmet Chem
. 1982;33:179 – 191.
65.
Majors, P. A., Wild, J. E.: The evaluation of antiperspirant efficacy – influence of certain variables.
J Soc Cosmet
Chem
. 1974;25:139 – 152.
66.
Juneja, P. S.: Deodorant gel sticks containing 1-hydroxy pyridinethione active EP 0662817 A1
67.
Geria, N.: Formulation of stick antiperspirants and deodorants.
Cosmet Toiletries.
1984;99:55 – 66.
68.
Chadwick, J.: Aerosol anatomy, aerosol product litigation – Part 2,
Spray
, 2007;11:20 – 22.
69.
Andrasik, M. J.: Deodorants and Antiperspirants,
Int Fabr Instit Bullet, 626
, Accessed 3/12/2014 at
http://70.88.161.72/ifi/BULLETIN/TOI/Toi626.pdf
70.
Meilgaard, M. C., Carr, B. T., Civille, G. V.:
Sensory Evaluation Techniques
, 4th Edition, Boca Raton: CRC
Press, 2006.
71.
Maxeiner, B., Ennen, J., Rützel-Grünberg, S., et al.: Design and application of a screening and training protocol
for odour testers in the field of personal care products.
Int J Cosmet Sci
. 2009;31(3):193 – 199.
72.
Smits, J., Senti, B., Herbst, N.: usNeoTM - a Naturally Effective Deodorant and Antibac- terial Active.
Cosmet
Sci Technol.
2012;1 – 8.
73.
Rexona Men Maximum Protection, Accessed 3/8/2014 at http://www.unilever.com/
brands-in-action/detail/
Rexona/292102/
74.
Lady Speed Stick Clinical Proof, Accessed 3/8/2014 at http://dailymed.nlm.nih.gov/
dailymed/lookup.
cfm?setid
=
6137b038-dcfd-4ef6-9a59-45e19dc3807a
75.
Old Spice Fresh Invisible Solid, Accessed 3/8/2014 at http://www.oldspice.com/en-
US/products/product/20/
old-spice-high-endurance-antiperspirantdeodorant-invisible- solid-fresh/
76.
Secret Invisible Protection Outlast, Accessed 3/8/1014 at http://www.secret.com/
Outlast-InvisibleSolid.aspx
77.
CFR Title 21 Part 350.60
78.
Guidelines for Effectiveness Testing of OTC Antiperspirant Drug Products, Accessed 3/10/2014 at http://www.
fda.gov/downloads/AboutFDA/CentersOffices/CDER/ucm
106437.pdf
79.
Rados C.: Antiperspirant Awareness: It’s Mostly No Sweat.
FDA Consumer Mag- azine.
2005, Accessed
2/3/2014 at www.medicinenet.com/script/main/art.asp?
articlekey
=
53207
80.
American Cancer Society: Antiperspirants and Breast Cancer Risk, Last update: 9/20/2013, Accessed
3/10/2014 at http://www.cancer.org/cancer/cancer
causes/othercarcinogens/athome/antiperspirants-and-breast-
cancer-risk
81.
Mirick, D. K., Davis, S., Thomas, D. B.: Antiperspirant use and the risk of breast cancer.
J Natl Cancer Inst
.
2002;94(20):1578 – 1580.
82.
Gikas, P. D., Mansfield, L., Mokbel, K.: Do underarm cosmetics cause breast cancer?
Int J Fertil Womens Med
.
2004;49(5):212 – 214.
83.
Namer, M., Luporsi, E., Gligorov, J., et al.: The use of deodorants/antiperspirants does not constitute a risk factor
for breast cancer.
Bull Cancer
. 2008;95(9):871 – 880.
84.
Darbre, P. D.: Aluminium, antiperspirants and breast cancer.
J Inorg Biochem
. 2005;99(9):1912 – 1919.
85.
McGrath, K. G.: An earlier age of breast cancer diagnosis related to more fre- quent use of antiperspirants/
deodorants and underarm shaving.
Eur J Cancer Prev
. 2003;12(6):479 – 485.
280
86.
Flarend, R., Bin, T., Elmore, D., et al.: A preliminary study of the dermal absorption of alu- minium from
antiperspirants using aluminium.
Food Chem Toxicol
. 2001;39(2):163 – 168.
87.
Rodrigues-Peres, R. M., Cadore, S., Febraio, S., et al.: Aluminum concentrations in central and peripheral areas of
malignant breast lesions do not differ from those in normal breast tissues.
BMC Cancer
. 2013;13:104.
88.
Fact Sheet: Antiperspirants/Deodorants and Breast Cancer, Last update: 1/4/2008, Accessed 2/27/2014 at http://
www.cancer.gov/cancertopics/factsheet/Risk/AP-Deo
89.
CFR Title 21 Part 350.50(c) Labeling of antiperspirant drug products.
90.
FDA: Parabens, Last update: 3/20/2014, Accessed 2/27/2014 at http://www.fda.gov/
cosmetics/
productandingredientsafety/selectedcosmeticingredients/ucm128042.html
91.
Alzheimer News 2/02/2005, Accessed 3/11/2014 at http://www.alz.org/news_and_events_
alzheimer_news_02-
02-2005.asp
92.
D. F. Williams, W. H. Schmitt:
Chemistry and Technology of the Cosmetics and Toiletries Industry
, Springer,
1996:321.
93.
42 FR 24,536
94.
EPA: Cleaning Up Commonly Found Air Pollutants, Accessed 2/12/2014 at http:// www.epa.gov/airquality/
peg_caa/cleanup.html
95.
CFR Part 59 — National Volatile Organic Compound Emission Standards for Consumer and Commercial Products
(Current as of 12/12/2013)
96.
California Air Resourced Board: Final Regulation Order, Regulation for Reducing Volatile Organic Compound
Emissions from Antiperspirants and Deodorants, Subchapter 8.5. Consumer Products, Article 1. Antiperspirants
and Deodorants
281
282
Достарыңызбен бөлісу: |